PharmaNordic ApS: Financial statements 2025
CVR: 36408464
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
PharmaNordic ApS (CVR 36408464) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -197,662 and a net result of DKK 2,313,695 compared with DKK 647,775 the year before. Equity in the 2025 report amounted to DKK 4,025,013. The solvency ratio was 99.6%. The company had 1 employee in the financial year.
- Gross Profit
- DKK -197,662
- Profit/Loss
- DKK 2,313,695
- Equity
- DKK 4,025,013
- Total Assets
- DKK 4,039,587
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | -198 t. | 2.3 mio. | 4 mio. | 1 |
| 2024 | - | 594 t. | 648 t. | 1.8 mio. | 1 |
| 2023 | - | 723 t. | 515 t. | 1.2 mio. | 1 |
| 2022 | - | 575 t. | 183 t. | 673 t. | 1 |
| 2021 | - | 738 t. | 144 t. | 490 t. | - |
Official annual report
How creditworthy is PharmaNordic ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
PharmaNordic ApS has published its annual report for 2024. Gross profit came to DKK 593,730, and the net result was DKK 647,775.
About PharmaNordic ApS
PharmaNordic ApS is a Danish company of the type Anpartsselskab based in Greve, founded in 2014. The company is registered under the industry Planlægning og design af reklamekampagner. The management consists of Anders Lentini From. The company is owned by LENTINI HOLDING ApS. The company has 1 employee (2018). In 2025, the company reported a gross profit of DKK -197,662 and a net result of DKK 2,313,695 compared with DKK 647,775 the year before. Equity in the 2025 report amounted to DKK 4,025,013.